As per the report, the global coronary stents market is expected to reach a value of US$ 8,414.5 Mn by 2025, from US$ 5,244.9 Mn in 2017, with a promising CAGR of 6.1%. With the rising demand for drug eluting stents, the global coronary stents market is prognosticated to witness rapid growth in the coming years.
Increasing Demand for Self-Expandable Stents to Augment Growth
Manufacturers have introduced next generation drugs in the drug eluting stents segment. The widespread distribution of drug eluting systems around the world is likely to help this segment emerge dominant. In 2017, the drug eluting stents systems segment accounted for 65.8% share in the market. This segment is also expected to continue dominating the market during the forecast period.
Similarly, the self-expandable stents segment will show faster growth among other segments based on deployment. This is owing to the expansion of the regional and local markets for coronary stent material across the globe. In addition to this, clinically proven efficiency of self-expandable stents as compared to its counterparts will boost the coronary stents market.
According to the Centre for Disease Control and Prevention, about one-third of the population in the U.S. is obese. The change in lifestyle such as physical inactivity, smoking, drinking, and mistimed and unhealthy food habits are among the major reasons leading to health problems such as obesity, hypertension, arterial blockage, and others.
Price Capping System in India, Propelling Asia Pacific to Emerge as Fastest Growing Market
The presence of a majority of manufacturers in Canada and the U.S. has enabled the North America coronary stent market to e merge dominate. Besides this, the increasing prevalence sedentary lifestyle among people in several developed countries is also fueling demand for coronary stents in the regional market, thus making North America the leading region in the global market.
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
By Stent Type
· Drug-Eluting Stent
· Bioresorbable Stent
· Bare Metal Stent
· Covered Stent
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
The competitive landscape of the global coronary stents market is consolidated with top five market players holding a prominent share. These companies are not only investing hugely in research and development but also launching improved products in order to improve their market share post approval. Some of the key companies operating in the global coronary stents market are Medtronic, Abbott, Terumo Corporation, C. R. Bard, Inc., Cardinal Health, Boston Scientific Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Cook, and Biotronik SE & Co. KG.
TABLE OF CONTENT:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Coronary Artery Diseases (CAD)- Key Countries, 2017
4.2 Health Reimbursement Scenario-Key Countries
4.3 Regulatory Scenario- Key Countries
4.4 Pricing Analysis
4.5 Key Industry Developments -Partnerships, Mergers & Acquisitions